glp 1 peptides retatrutide What is Retatrutide? – theclinicroom Retatrutide Research: Triple Agonist Mechanism

1 Nauck MA, Quast DR, Wefers J, Pfeiffer AFH

Bioinformatic analyses on publicly-available patient RNA-sequencing data (n=664) identified significantly higher GLP1R expression in advanced prostate cancer vs

Common gastrointestinal effects reported with GLP-1 therapy include: Nausea (commonly reported, especially during dose escalation) Constipation or diarrhoea Abdominal discomfort or bloating Reduced appetite and early satiety Regarding bowel movement colour specifically, changes in stool colour are not listed as adverse effects in UK SmPCs for GLP-1 receptor agonists

Weight regain commonly occurs after treatment discontinuation without sustainable lifestyle changes

This leptinGLP-1 action may be mediated in part by common and complementary intracellular signalling pathways (phosphorylated signal transducer and activator of transcription 3 [STAT3], PTP1B) [29]

Some wont yet the research is moving faster than the textbooks